Fig. 6
From: Identification and validation of platinum resistance signature in gastric cancer
GSEA and GSVA analysis. A-B. GSEA-GO analysis: the promoted (A) and inhibited (B) biological processes in the samples with high drug resistance scores. C-D. GSEA-KEGG analysis: the promoted (C) and inhibited (D) biological processes in the high drug resistance score samples. E. The GSVA score of hallmarks between samples with high and low drug resistance scores, *P < 0.05; **P < 0.01; ***P < 0.001. F. The correlation between hallmarks and drug resistance score